The store will not work correctly when cookies are disabled.
(E)-2-(4-Hydroxy-3-methoxybenzylidene)-6-isopropoxy-2,3-dihydro-1H-inden-1-one
ID: ALA4745825
Chembl Id: CHEMBL4745825
PubChem CID: 141532344
Max Phase: Preclinical
Molecular Formula: C20H20O4
Molecular Weight: 324.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(/C=C2\Cc3ccc(OC(C)C)cc3C2=O)ccc1O
Standard InChI: InChI=1S/C20H20O4/c1-12(2)24-16-6-5-14-10-15(20(22)17(14)11-16)8-13-4-7-18(21)19(9-13)23-3/h4-9,11-12,21H,10H2,1-3H3/b15-8+
Standard InChI Key: OJMQQBBFGXKAER-OVCLIPMQSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.38 | Molecular Weight (Monoisotopic): 324.1362 | AlogP: 4.01 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.48 | CX Basic pKa: ┄ | CX LogP: 4.05 | CX LogD: 4.04 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.86 | Np Likeness Score: 0.05 |
References
1. Huo PC,Hu Q,Shu S,Zhou QH,He RJ,Hou J,Guan XQ,Tu DZ,Hou XD,Liu P,Zhang N,Liu ZG,Ge GB. (2021) Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors., 29 [PMID:33214035] [10.1016/j.bmc.2020.115853] |
2. Huo PC,Guan XQ,Liu P,Song YQ,Sun MR,He RJ,Zou LW,Xue LJ,Shi JH,Zhang N,Liu ZG,Ge GB. (2021) Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors., 209 [PMID:33007602] [10.1016/j.ejmech.2020.112856] |